Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Varenicline Treatment for Active Alcoholic Smokers

NCT01347112 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT01347112
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01347112 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Varenicline Treatment for Active Alcoholic Smokers
Lead sponsor
Mayo Clinic
Phase
Phase 2/3
Overall status
Completed
Start date
June 30, 2011
Completion date
March 31, 2014
Enrollment
33 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence, smoking, tobacco dependence